Health IT Analytics March 25, 2020
Jessica Kent

Researchers are using machine learning algorithms capable of generating millions of therapeutic antibodies to quickly find treatments for COVID-19.

Using machine learning algorithms, two data scientists are working to quickly discover effective treatments for COVID-19.

For more coronavirus updates, visit our resource page, updated twice daily by Xtelligent Healthcare Media.

Andrew Satz and Brett Averso, graduates of the Data Science Institute at Columbia University, have launched a startup called EVQLV that creates algorithms capable of computationally generating, screening, and optimizing hundreds of millions of therapeutic antibodies.

Using this technology, the pair is working to discover treatments that will most likely help individuals infected by the virus that causes COVID-19. The machine learning algorithms are able to rapidly screen for therapeutic...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Provider, Technology
STAT+: After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates
Alphabet shares jump 14% on earnings beat, first-ever dividend
Microsoft: Unlocking AI Benefits Will Require Cultural Changes for Enterprises
Zephyr AI Raises $111 Million in Series A Financing
Chatbot answers are all made up. This new tool helps you figure out which ones to trust.

Share This Article